Overall risk of bias assessment. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Funnel plot of VO_2Peak inclusion studies. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Analysis of subgroups. by Da Huang (1306407)

“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”

Key Resources. by Jeffrey Chin (22538086)

“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”

Tax1bp1-deficiency reduces autophagy flux. by Jeffrey Chin (22538086)

“…Unexpectedly, we found that Tax1bp1-deficient mice were less susceptible to <i>Mtb</i> infection, and generated reduced inflammatory cytokine responses, compared to wild-type mice; the same mutant mice exhibited decreased growth of, and inflammatory cytokine responses to, <i>Listeria monocytogenes</i>, suggesting that Tax1bp1 plays a role in host responses to multiple intracellular pathogens. …”

Case Fatality Ratio Differences. by Mwandida Kamba Afuleni (20917902)

Study data. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Summary of clinical outcomes after 9 months. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Approval by the research ethics committee. by Jie Liu (15128)

“…</p><p> Conclusion </p><p>During the COVID-19 pandemic, both roxadustat and ESAs effectively improved renal anemia in PD patients, however, the roxadustat group experienced less additional costs for anemia correction and better medication compliance.…”

Risk Illustration. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Predictors of SCD. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Clinical outcomes. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Obesity and Depressed Ejection Fraction. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Kaplan Meier curve. by Iftikhar Ali Ch (20783753)

“…Similarly, patients with EF > 40% had decreased incidence of SCD compared to those with EF < 40% (HR 0.347, 95% CI:0.158–0.763; p = 0.008). …”

Community consumption of J01 antibiotics at national and state levels expressed as DDD per 1000 inhabitants and per day (DID), Brazil, 2014−2020. by Tatiana de Jesus Nascimento Ferreira (21492903)

Community consumption of systemic antibiotics, according to Therapeutic Subgroup ATC 3^rd level, expressed as DDD per 1000 inhabitants and per day (DID) and relative cons... by Tatiana de Jesus Nascimento Ferreira (21492903)

TITAN analyses. by Erik W. Ertsgaard (20521628)

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

A Novel Type of PSMA-Targeting Ligands via β‑Branched Aromatic α‑Amino Acid Modification, Bearing Enhanced Tumor Targeting and Reduced Renal Toxicity by Zong-Xiao Liu (22177765)

“…With average renal uptake of less than 10%ID/g, as opposed to 25%ID/g for [⁶⁸Ga]Ga-<b>PSMA-617</b>, this substantial decrease in renal accumulation translates to a significantly improved safety profile by minimizing nephrotoxic risks. …”

S1 Data - by Jan Willem Koten (17743224)

“…The mean connectivity decreased to r = 0.09 (95% CI 0.03–0.16) when test-retest reliability and auto-correlations of single time courses were considered, indicating that less than a quarter of connectivity is detectable. …”